A Meta-Analysis of Two Double-Blind, Placebo Controlled, Randomized Trials to Evaluate the Efficacy and Safety of Carvedilol Treatment in Non-Dialysis Dependent Chronic Kidney Disease Patients with Symptomatic or Asymptomatic Systolic Heart Failure Meeting Abstract (Web of Science)
Industry Collaboration